Close
Who We Are
Leadership Team
Board of Directors
Environmental, Social, and Governance (ESG) Commitment
Justice, Equity, Diversity, and Inclusion Commitment
Our Platform
Posters & Publications
Our Pipeline
Inflammatory Diseases
Patients, Families & Physicians
Investors & Media
News & Events
SEC Filings
Stock
Analyst Coverage
Governance
Careers
Contact Us
Skip to main content
Skip to footer
Evelo
Menu
Commensal
Bifidobacterium
promotes antitumor immunity and facilitates anti–PD-L1 efficacy
Home
/
Publications
/
Commensal Bifidobacterium promotes antitumor immunity and facilitates anti–PD-L1 efficacy
November 27, 2015
by
